RT Journal Article
SR Electronic
T1 Pulmonary function and risk of Alzheimer dementia: two-sample Mendelian randomization study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.28.20163352
DO 10.1101/2020.07.28.20163352
A1 Tom C. Russ
A1 Sarah E. Harris
A1 G. David Batty
YR 2020
UL http://medrxiv.org/content/early/2020/09/07/2020.07.28.20163352.abstract
AB Dementia is a major global public health concern and in addition to recognised risk factors there is emerging evidence that poorer pulmonary function is linked with subsequent dementia risk. However, it is unclear if this observed association is causal or whether it might result from confounding. Therefore, we present the first two-sample Mendelian randomisation study of the association between pulmonary function and Alzheimer dementia using the most recent genome-wide association studies to produce instrumental variables for both. We found no evidence of a causal effect of reduced Forced Expiratory Volume in 1 second (FEV1) or Forced Vital Capacity (FVC) on Alzheimer dementia risk (both P>0.35). However, the FEV1/FVC ratio was associated with Alzheimer dementia risk with, in fact, superior function predicting an increased dementia risk (β=0.11, P=0.016) which may result from survivor bias. While we can conclude that there is no causal link between impaired pulmonary function and Alzheimer dementia, our study sheds less light on potential links with other types of dementia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis article received no specific funding. The Alzheimer Scotland Dementia Research Centre is funded by Alzheimer Scotland. The Lothian Birth Cohorts are funded by Age UK. TCR is employed by the UK National Health Service and the Scottish Government. GDB is supported by the UK Medical Research Council (MR/P023444/1) and the US National Institute on Aging (1R56AG052519-01; 1R01AG052519-01A1). All researchers are independent of their funders.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available.